News

Long COVID resurfaces in the national dialogue after long absence from the headlines

In early 2025 public health researchers at City University of New York projected Long COVID would cost the U.S. $6.6 billion over three years. This week two members of that research team amplified their findings and updated their projections.

5 points of light in the darkness of ‘healthcare’s moral emergency’

Western medicine often functions more like a high-tech patient-processing machine than a high-touch people-healing mission. This can and must change, argue three distinguished healthcare thought leaders.

FDA warns public about Johnson & Johnson heart pump controllers after patient death

The FDA has identified another safety concern with Johnson & Johnson MedTech's Automated Impella Controllers. This comes after the devices were linked to five separate recalls in 2025.

Advocacy group wants TAVR changes, urging Trump admin to ‘stop getting in between patients and their doctors’

The Alliance for Aging Research wants CMS to go through with policy changes that could make many more patients eligible for TAVR. The agency is currently considering the changes, and a final decision is expected in June.

warning safety alert recall healthcare issue

Medtronic recalls thousands of surgical devices due to contamination risk

This Class II recall includes more than 18,000 cannulae used during cardiac surgery.

Jupiter Endovascular's Vertex Pulmonary Embolectomy System showed positive results in its SPIRARE II pivotal trial.

'Compelling' study shows promise of new pulmonary embolectomy system

"Pulmonary embolism is fundamentally a cardiovascular disease, where restoration of hemodynamic stability, beyond simple clot removal, is the key determinant of patient recovery,” one researcher explained.

Data breach on New York public health system claims 1.8M victims, leaking biometric data to hackers

First revealed in March, the incident was confirmed to be months long. NYC Health + Hospitals blamed the intrusion on an unnamed third-party vendor. Stolen data includes medical records, finger and palm prints, and location data from patients and workers alike.

Trump administration appoints temporary surgeon general as radiologist nominee awaits hearings

HHS Secretary Robert F. Kennedy Jr. is tapping Stephanie Haridopolos, MD, to temporarily fill the role and carry out some of the duties handled by the “nation’s doctor.”

New findings support the selective gamification of radiology education

Radiology residents can receive meaningful clinical training via game playing—and they largely appreciate the experience, new research shows.

Tandem Diabetes Care is recalling a recent update of the mobile app for its t:slim X2 insulin pump due to repeated software issues that may cause the pump to shut down unexpectedly. The FDA has said this is a Class I recall.

Insulin pump error linked to 700 adverse events

Speaker issues are causing the devices to stop communicating with the user's CGM. Dozens of patient injuries have been reported, and the company is prepping a software update.

Molecular Imaging PET and SPECT sign in GE booth ACC23.

Shine working toward U.S. production of Mo-99 for SPECT imaging

Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.

cardiologists going through the certification process

Hemodynamic deterioration 1 year after TAVR found in 6% of patients

Hemodynamic valve deterioration after one year was more common in patients with a small aortic annulus. In fact, receiving a larger valve was linked to a “protective” quality that appeared to help keep the risk of such complications to a minimum.

Around the web

Health Exec

Long COVID resurfaces in the national dialogue after long absence from the headlines

Health Exec

5 points of light in the darkness of ‘healthcare’s moral emergency’

Cardiovascular Business

FDA warns public about Johnson & Johnson heart pump controllers after patient death

The FDA has identified another safety concern with Johnson & Johnson MedTech's Automated Impella Controllers. This comes after the devices were linked to five separate recalls in 2025.